Literature DB >> 15068969

Exogenous liposomal IGF-I cDNA gene transfer leads to endogenous cellular and physiological responses in an acute wound.

Marc G Jeschke1, Thomas Schubert, Dagmar Klein.   

Abstract

The purpose of the present study was to examine whether exogenous liposomal cDNA gene transfer is recognized by the cell and causes endogenous cellular and physiological responses. When administered as a protein, IGF-I is known to cause adverse side effects due to lack of cellular responses. Therefore, we used IGF-I cDNA as a vector to study cellular and physiological effects after liposomal administration to wounded skin. Sprague-Dawley rats were given a scald burn to inflict an acute wound and were divided into two groups to receive weekly subcutaneous injections of liposomes plus the Lac-Z gene (0.2 microg vehicle) or liposomes plus the IGF-I cDNA (2.2 microg) and Lac Z gene (0.22 microg). Transfection was confirmed by histochemical assays for beta-galactosidase. Planimetry, immunological assays, and histological and immunohistochemical techniques were used to determine molecular mechanisms after gene transfer, protein expression, and dermal and epidermal regeneration. IGF-I cDNA transfer increased IGF-I protein expression and caused concomitant cellular responses by increasing IGF binding protein (IGFBP)-3 and decreasing IGFBP-1. IGF-I cDNA gene transfer increased keratinocyte growth factor expression and exerted promitogenic antiapoptotic effects on basal keratinocytes, thus improving epidermal regeneration. IGF-I cDNA improved dermal regeneration by an increased collagen deposition and morphology. IGF-I cDNA increased VEGF concentrations and thus neovascularization. Exogenous-administered IGF-I cDNA is recognized by the cell and leads to similar intracellular responses as the endogenous gene. Liposomal IGF-I gene transfer further leads to improved dermal and epidermal regeneration by interacting with other growth factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15068969     DOI: 10.1152/ajpregu.00541.2003

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  7 in total

1.  Ganglioside GM3 Mediates Glucose-Induced Suppression of IGF-1 Receptor-Rac1 Activation to Inhibit Keratinocyte Motility.

Authors:  Duncan Hieu M Dam; Xiao-Qi Wang; Sarah Sheu; Mahima Vijay; Desmond Shipp; Luke Miller; Amy S Paller
Journal:  J Invest Dermatol       Date:  2016-10-08       Impact factor: 8.551

Review 2.  Wound coverage technologies in burn care: novel techniques.

Authors:  Marc G Jeschke; Celeste C Finnerty; Shahriar Shahrokhi; Ludwik K Branski; Manuel Dibildox
Journal:  J Burn Care Res       Date:  2013 Nov-Dec       Impact factor: 1.845

Review 3.  A review of gene and stem cell therapy in cutaneous wound healing.

Authors:  Ludwik K Branski; Gerd G Gauglitz; David N Herndon; Marc G Jeschke
Journal:  Burns       Date:  2008-07-07       Impact factor: 2.744

4.  Overexpression of mIGF-1 in keratinocytes improves wound healing and accelerates hair follicle formation and cycling in mice.

Authors:  Ekaterina Semenova; Heidi Koegel; Sybille Hasse; Jennifer E Klatte; Esfir Slonimsky; Daniel Bilbao; Ralf Paus; Sabine Werner; Nadia Rosenthal
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

5.  The use of growth factors and other humoral agents to accelerate and enhance burn wound healing.

Authors:  Yiu-Hei Ching; Thomas L Sutton; Yvonne N Pierpont; Martin C Robson; Wyatt G Payne
Journal:  Eplasty       Date:  2011-11-07

Review 6.  [Role of gene therapy in trauma and orthopedic surgery].

Authors:  A Oberholzer; P Stahel; S K Tschöke; W Ertel
Journal:  Unfallchirurg       Date:  2006-07       Impact factor: 1.000

7.  Ganglioside GM3 depletion reverses impaired wound healing in diabetic mice by activating IGF-1 and insulin receptors.

Authors:  Xiao-Qi Wang; Sarah Lee; Heather Wilson; Mark Seeger; Hristo Iordanov; Nandita Gatla; Adam Whittington; Daniel Bach; Jian-Yun Lu; Amy S Paller
Journal:  J Invest Dermatol       Date:  2013-12-10       Impact factor: 8.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.